Jang-Hyuck Han

Title: Innovations by Jang-Hyuck Han: A Pioneer in Vaccine Development

Introduction

Jang-Hyuck Han, a notable inventor based in Chungcheongnam-do, South Korea, has made significant contributions to the field of biotechnology, particularly in vaccine development. With one patent to his name, his work focuses on advancing treatments for Newcastle disease, a severe viral infection affecting birds.

Latest Patents

The key patent filed by Jang-Hyuck Han is titled "Attenuated recombinant Newcastle disease virus and vaccine containing the same." This innovative patent relates to a recombinant vector for the transcription of the Newcastle disease virus (NDV) genome. The invention includes a strain of attenuated recombinant NDV with a surface antigen of pathogenic NDV and describes a method for preparing a recombinant NDV that has low pathogenicity and high protective efficiency against Newcastle disease, along with the vaccine incorporating this recombinant NDV.

Career Highlights

Jang-Hyuck Han has gained valuable experience in the biotechnology industry, contributing his expertise to Kbnp, Inc. and Biopoa, Inc. His work in these companies underscores his commitment to advancing health solutions, particularly in combating infectious diseases through innovative vaccine technology.

Collaborations

Throughout his career, Jang-Hyuck Han has collaborated with noteworthy individuals in the field, including Sun-Hee Cho and Hyuk-Joon Kwon. These partnerships highlight the collaborative nature of scientific research, which often leads to significant breakthroughs in technology and medicine.

Conclusion

Jang-Hyuck Han's contributions to vaccine development and his patent on an attenuated recombinant Newcastle disease virus demonstrate the pivotal role of inventors in advancing public health. His innovative work exemplifies the importance of research and collaboration in creating effective solutions to complex challenges in the field of biotechnology.